MEDICAF
ActiveSummary
MEDICAF has been active since 2002 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €264k and a net result of €44k. Equity is growing by ~12.8% per year across the filed fiscal years. Its solvency ranks better than 21% of 1247 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
61
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability46▼-1
Solvency45▲+3
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €16k at 30 days acceptable
Liquidity tight (current ratio 1.36 against 1.31 in 2023; short-term debt: 34.1% and cash: 0% of total assets), and 80% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 21% of 1247 sector peers (2024).
NBB · sector comparisonPosition among 1247 sector peers
Solvency
better than 21%
← weakest
strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-09-2025, 61 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
61 d late
2023
61 d late
2022
112 d late
2021
150 d late
2020
109 d late
2019
91 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€44k▼ 12.7%
2023 · €50k
2018: €11k
2019: €9k
2020: €7k
2021: €17k
2022: €18k
2023: €50k
2018 → 2024
Working capital
€163k▲ 23.4%
2023 · €132k
2018: €64k
2019: €66k
2020: €66k
2021: €75k
2022: €94k
2023: €132k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€136k-€153k▲ 12.2%€170k▲ 11.5%€220k▲ 29.3%€264k▲ 19.8%
Operating result€54k-€64k▲ 17.4%€60k▼ 5.8%€96k▲ 59.2%€86k▼ 9.6%
Net result€7k-€17k▲ 147%€18k▲ 5.6%€50k▲ 185%€44k▼ 12.7%
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 10% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €1.32M
Fixed assets
€707k =
Current assets
€613k ▲ 8.6%
Equity and liabilities €1.32M
Equity
€264k ▲ 19.8%
Provisions
€606k ▼ 2.0%
Debt
€450k ▲ 4.1%
The debt ratio rises from 34.0% to 34.1%. Equity and debt are higher.
Key figures and ratios
Current ratio
1.36▲
2023 · 1.31
Debt / equity
1.71▼
2023 · 1.96
ROE
16.5%▼
2023 · 22.7%
ROA
3.3%▼
2023 · 3.9%
Debt ≤ 1 year
€450k▲
2023 · €432k
Income taxes
€18k▲
2023 · €15k
Staff costs
€46k▲
2023 · €12k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 51 lines
Balance sheet
Code20232024
Assets
Total assets20/58€1.27M€1.32M▲
Fixed assets21/28€707k€707k=
Financial fixed assets28€707k€707k=
Current assets29/58€564k€613k▲
Amounts receivable after more than one year29€0-
Other amounts receivable291€0-
Amounts receivable within one year40/41€553k€611k▲
Other amounts receivable41€553k€611k▲
Cash at bank and in hand54/58€131€33▼
Deferred charges and accrued income490/1€11k€2k▼
Equity and liabilities
Total equity and liabilities10/49€1.27M€1.32M▲
Equity10/15€220k€264k▲
Contributions10/11€19k€19k=
Reserves13€35k€78k▲
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€33k€77k▲
Profit (loss) carried forward14€167k€167k=
Provisions and deferred taxes16€618k€606k▼
Provisions for liabilities and charges160/5€618k€606k▼
Other liabilities and charges164/5€618k€606k▼
Amounts payable17/49€432k€450k▲
Amounts payable within one year42/48€432k€450k▲
Current portion of amounts payable after more than one year42€6k€6k=
Financial debts43€621€630▲
Credit institutions430/8€621€630▲
Trade debts44€17k€13k▼
Suppliers440/4€17k€13k▼
Taxes, remuneration and social security45€32k€67k▲
Taxes450/3€25k€50k▲
Remuneration and social security454/9€7k€17k▲
Other amounts payable47/48€377k€364k▼
Income statement
Code20232024
Non-recurring operating income76A€5k-
Remuneration, social security and pensions62€12k€46k▲
Provisions for liabilities and charges: additions (uses and reversals)635/8€-12k€-13k▼
Other operating charges640/8€7k€5k▼
Gross operating margin9900€103k€125k▲
Operating profit (loss)9901€96k€86k▼
Financial income75/76B€26k€35k▲
Recurring financial income75€26k€35k▲
Financial charges65/66B€57k€60k▲
Recurring financial charges65€57k€60k▲
Profit (loss) for the period before taxes9903€65k€62k▼
Income taxes67/77€15k€18k▲
Profit (loss) for the period9904€50k€44k▼
Profit (loss) for the period to be appropriated9905€50k€44k▼
Appropriation of the result
Profit (loss) to be appropriated9906€167k€210k▲
Profit (loss) brought forward from the previous period14P€117k€167k▲
Transfer to equity691/2-€44k
To other reserves6921-€44k
Social balance
Average headcount (FTE)90871.0-
The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
30-09
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 61 days late
2024
30-09
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 61 days late
2023
31-12
Financial
Highest result since 2018net €50k ▲185%
Operating result €96k, net result €50k, both a record.
31-12
Financial
Equity above €200kEq €220k ▲29.3%
6 profitable years in a row build equity to €220k.
20-11
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 112 days late
2022
28-12
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 150 days late
2021
31-12
Financial
Equity above €150kEq €153k ▲12.2%
4 profitable years in a row build equity to €153k.
17-11
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 109 days late
2020
31-12
Financial
Weakest financial yearnet €7k ▼23.8%
Net result drops to €7k, the lowest in the series; recovery starts the following year.
30-10
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 91 days late
2019
30-09
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 61 days late
2018
30-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 30 days late
2017
27-09
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 58 days late
2016
30-08
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Elsene · 1 establishment unit since 2002
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Louizalaan 2841050 ElseneGround area
1,955 m²
Building footprint
311 m²
Volume, LiDAR
7,232 m³
2 parcels, Brussels, Wallonia · tallest building 31.9 m, ±10 floors. Linked by address, not a title deed.
1 establishment unit
MEDICAF
since 20022.165.312.093
2 parcels
Wallonia
1
(50%)
Brussels
1
(50%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25051C0125/00H000 | Wallonia | 1,434 m² | 1 · 73 m² | 9.9 m · 2 fl. |
| 21807G0148/00Z003 | Brussels | 520 m² | 1 · 238 m² | 31.9 m · 10 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
AREX MEDICAL
BE 0737.645.210
Zaventem · Eq €264k
Medivive
BE 0640.993.123
Roeselare · Eq €264k
ESCULAPE
BE 0462.295.367
Waimes · Eq €264k
NOSELE
BE 0876.435.778
Sint-Pieters-Woluwe · Eq €264k
DOCTEUR KIROVA MARIA
BE 0723.426.592
Saint-Ghislain · Eq €264k
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 6,680 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded02-12-2002
Fiscal year end31-12
Activities, NACEBEL
85120
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 20 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.